Patients can lose up to 10%-16% of their body weight over 12 to 15 months by combining semaglutide with healthy habits, a balanced diet, and exercise
Weight stigma is linked to poorer mental health, so it is unsurprising that Ozempic users experiencing weight loss may experience improved mood
The development and market approval of novel direct-acting antivirals (DAAs), such as sofosbuvir by itself or in combination with ledipasvir molecules currently available in Tunisia have dramatically changed the hepatitis C virus treatment landscape
Its not a substitute for professional medical advice, diagnosis, or treatment
Tirzepatide is an approved, extensively studied dual agonist with a proven safety record, commercial availability, and the most comprehensive Phase 3 dataset in the GLP-1 class